Literature DB >> 268933

Haemodynamic effects of pindolol in hypertensive patients.

J H Atterhög, H Dunér, B Pernow.   

Abstract

Five men and five women, mean age 48 years, with hypertension in stages I or II of the WHO classification, were given preoral treatment with pindolol. The pindolol treatment lead a significant decrease in the systolic and diastolic blood pressure, at rest and during work both after 2 months and after 16 months treatment. Three mechanisms seem to be involved in the antihypertensive effect of pindolol: 1) a negative chronotropic effect on the heart, 2) a decrease in peripheral vascular resistance and 3) an increase in venous capacitance affecting the venous return. Comparison of the results after 2 and after 16 months of treatment suggests that a decrease in cardiac output is an early mechanism in the lowering of the blood pressure, while a decrease in vascular resistance seems to be more important after long-term treatment with pindolol.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 268933     DOI: 10.1111/j.0954-6820.1977.tb18030.x

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN: 0365-463X


  6 in total

1.  Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoreceptor blockade by labetalol.

Authors:  G Koch
Journal:  Br Heart J       Date:  1979-02

2.  Long-term hemodynamic effects of penbutolol at rest and during exercise in essential hypertension.

Authors:  P Lund-Johansen
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

3.  Effect of celiprolol on large and small arteries of the forearm circulation in hypertensive patients.

Authors:  O Roman; N Meza; C Klenner
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

4.  Responses of glomerular filtration, renal blood flow and salt-water handling to acute cardioselective and non-selective beta-adrenoceptor blockade in essential hypertension.

Authors:  G Koch; L Fransson; L Karlegärd; P Kothari
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 5.  Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.

Authors:  P Lund-Johansen
Journal:  Drugs       Date:  1984       Impact factor: 9.546

6.  Adaptation of hypertensives to treatment with cardioselective and non-selective beta-blockers. Absence of correlation between bradycardia and blood pressure control, and reduction in slope of the QT/RR relation.

Authors:  E M Williams; M O Hassan; J S Floras; P Sleight; J V Jones
Journal:  Br Heart J       Date:  1980-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.